risperidone has been researched along with Agenesis of Hemidiaphragm in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"This short report provides guidance for antipsychotic medication dosing to improve early intervention outcomes." | 1.56 | Early behavioral and developmental interventions in ADNP-syndrome: A case report of SWI/SNF-related neurodevelopmental syndrome. ( Hopkin, R; Pedapati, E; Shillington, A; Suhrie, K, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Shillington, A | 1 |
Pedapati, E | 1 |
Hopkin, R | 1 |
Suhrie, K | 1 |
1 other study available for risperidone and Agenesis of Hemidiaphragm
Article | Year |
---|---|
Early behavioral and developmental interventions in ADNP-syndrome: A case report of SWI/SNF-related neurodevelopmental syndrome.
Topics: Antipsychotic Agents; Autism Spectrum Disorder; Behavioral Symptoms; Child, Preschool; Early Medical | 2020 |